Single-use Bioreactors Market by Type, Application, Element - Global Trends and Forecast to 2032

1
Single-use Bioreactors Market Industry
Perspective, Comprehensive Analysis, Size, Share,
Growth, Segment, Trends and Forecast, 2032
2

• Industry Insights

• Single-use Bioreactors Market will register a
  15.5 CAGR from 2023 to 2032, propelled by the
  remarkable advancements in healthcare and the
  inherent flexibility of single-use bioprocessing
  technologies.
• The increasing demand for biopharmaceuticals,
  driven by a surge in precision medicine and
  therapeutic innovations, underscores the
  significance of these advancements.
• Single-use bioreactors, owing to their adaptable
  and cost-effective nature, emerge as pivotal
  tools in meeting the evolving needs of the
  healthcare sector, thereby significantly
  contributing to the industry landscape.
• For instance, in 2023, Getinge launched the
  AppliFlex ST GMP, an innovative single-use
  bioreactor system crafted to smoothly connect the
  realms of research and clinical production in
  cell and gene therapy, along with mRNA
  production. This launch bolsters the market share
  by seamlessly integrating cutting-edge healthcare
  advancements and the intrinsic flexibility of
  single-use bioprocessing technologies.

3

• The monoclonal antibodies (mAbs) segment will
  garner substantial gains through 2032. This
  prominence stems from the increasing therapeutic
  applications of mAbs, particularly in treating
  cancer and autoimmune diseases.
• Their high specificity, therapeutic efficacy, and
  rising demand for personalized medicine
  contribute to their prominence in bioprocessing.
• As the pharmaceutical landscape prioritizes
  precision and targeted therapies, the role of
  monoclonal antibodies within single-use
  bioreactors becomes pivotal, shaping the
  bioreactors market outlook.
• The bacterial cell segment will capture a
  remarkable revenue share by 2032 due to the
  widespread application of bacterial cells in
  various bioprocessing activities, including the
  production of vaccines, enzymes, and
  biotherapeutics. The versatility, scalability,
  and cost-effectiveness of utilizing bacterial
  cells contribute to their prominence. As the
  demand for biopharmaceuticals continues to
  escalate, the prevalence of bacterial cell-based
  processes will position them as a pivotal driver
  in carving a healthy market growth trajectory.

4

• Regional Analysis

• APAC single-use bioreactors market size will
  expand at a notable CAGR from 2023 to 2032,
  fueled by a confluence of factors, including the
  growing demand for biopharmaceuticals, increasing
  investments in research and development, and a
  burgeoning biotechnology sector. Favorable
  regulatory environments, in line with the
  region's robust manufacturing capabilities,
  contribute to its prominence.

• Competitive Analysis

• PBS Biotech
• Danaher Corporation
• Merck Group
• GEA Group Aktiengesellschaft
• Eppendorf AG
• CESCO Bioengineering Co. Ltd.
• CerCell ApS
• Cellexus Ltd

5
Single-use Bioreactors Market _at_
https//www.gminsights.com/industry-analysis/singl
e-use-bioreactors-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/6
940
Request for customization _at_ https//www.gminsights
.com/roc/6940
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com